"Lymphoma, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Descriptor ID |
D016399
|
| MeSH Number(s) |
C04.557.386.480.750 C15.604.515.569.480.750 C20.683.515.761.480.750
|
| Concept/Terms |
Lymphoma, T-Cell- Lymphoma, T-Cell
- Lymphoma, T Cell
- T-Cell Lymphoma
- Lymphomas, T-Cell
- T Cell Lymphoma
- T-Cell Lymphomas
|
Below are MeSH descriptors whose meaning is more general than "Lymphoma, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, T-Cell".
This graph shows the total number of publications written about "Lymphoma, T-Cell" by people in this website by year, and whether "Lymphoma, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 2 | 0 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 3 | 0 | 3 |
| 2013 | 1 | 0 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoma, T-Cell" by people in Profiles.
-
Wu Q, Ren F, Elston DM. Systemic Epstein-Barr virus-positive T-cell lymphoma of childhood. Cutis. 2019 Nov; 104(5):297-300.
-
Kommalapati A, Tella SH, Go RS, Bennani NN, Goyal G. A population-based analysis of second primary malignancies in T-cell neoplasms. Br J Haematol. 2019 04; 185(2):338-342.
-
Kailas A, Elston DM, Crater SE, Cerruto CA. Cutaneous intravascular CD30+ T-cell pseudolymphoma occurring in a regressing keratoacanthoma. J Cutan Pathol. 2018 Apr; 45(4):296-298.
-
McMahon BA, Moran RA, Sperati CJ, Bagnasco S, Novick T, Atta MG. Renal Thrombotic Microangiopathy, Podocytopathy, and Chylous Ascites: A Hard-Nosed Diagnosis. Am J Med. 2016 Oct; 129(10):e227-31.
-
Li Y, Chitnis N, Nakagawa H, Kita Y, Natsugoe S, Yang Y, Li Z, Wasik M, Klein-Szanto AJ, Rustgi AK, Diehl JA. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discov. 2015 Mar; 5(3):288-303.
-
Hassuneh MR, Nagarkatti M, Nagarkatti PS. Role of interleukin-10 in the regulation of tumorigenicity of a T cell lymphoma. Leuk Lymphoma. 2013 Apr; 54(4):827-34.
-
Opavsky R, Wang SH, Trikha P, Raval A, Huang Y, Wu YZ, Rodriguez B, Keller B, Liyanarachchi S, Wei G, Davuluri RV, Weinstein M, Felsher D, Ostrowski M, Leone G, Plass C. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet. 2007 Sep; 3(9):1757-69.
-
Yu J, Kindy MS, Gattoni-Celli S. Semi-allogeneic vaccine for T-cell lymphoma. J Transl Med. 2007 Aug 08; 5:39.
-
Park M, Liu GT, Piltz-Seymour J, Wisda CL, Rook AH, Junkins-Hopkins JM, Nasta SD, Kim EJ. Vision loss following denileukin diftitox treatment: a case report of possible posterior ischemic optic neuropathy. Leuk Lymphoma. 2007 Apr; 48(4):808-11.
-
Singh NP, Nagarkatti M, Nagarkatti PS. Role of dioxin response element and nuclear factor-kappaB motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of Fas and Fas ligand expression. Mol Pharmacol. 2007 Jan; 71(1):145-57.